Metastatic Triple Negative
1 clinical trials · Condition
◉ Watch Metastatic Triple Negative
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients (NCT02730130) | Memorial Sloan Kettering Cancer Center | 2016-06-03 |
Track Metastatic Triple Negative automatically
Every clearance here is in the API, with alerts when new ones post.